The Association of American Physicians and Surgeons (AAPS) recently filed a motion and amicus brief Thursday evening with the federal district court in Galveston urging it to allow the lawsuit to proceed against the FDA for its misleading statements against ivermectin, a drug used to fight parasites and given to covid patients during the early stages of infection.
In Apter v. HHS, a group of physicians sued to hold the Food and Drug Administration, a federal agency within the Department of Health & Human Services (HHS), accountable for its interference with physicians’ ability to treat Covid-19.“Defendant FDA has improperly exploited misunderstandings about the legality and prevalence of off-label uses of medication, in order to mislead courts, state medical boards, and the public into thinking there is anything improper about off-label prescribing,” AAPS writes in its amicus brief to the court. “Not only is off-label prescribing fully proper, legal, and commonplace, but it is also absolutely necessary in order to give effective care to patients.”Yet the FDA published multiple statements and sent letters to influential organizations to falsely disparage ivermectin, implying that it was not approved for treating Covid-19. Many, including courts and state medical boards, were misled by the FDA into thinking that its lack of approval for this treatment meant that ivermectin should not be used to treat Covid-19.
As a reminder, ivermectin was one of the topics in a particular “Second Opinion” panel that Senator Ron Johnson (R-WI) hosted earlier this year. Johnson gathered world-renowned doctors and medical experts to offer a different perspective on the pandemic: global pandemic response, the current state of knowledge of early and hospital treatment, vaccine efficacy and safety, what went right, what went wrong, what should be done now, and what needs to be addressed long term.
Dr. Pierre Kory is the former Chief of the Critical Care Service and Medical Director of the Trauma and Life Support Center at the University of Wisconsin and an expert in using “horse dewormer” ivermectin. He details the studies across the globe, including the success of its use in a Brazilian city and Uttar Pradesh, India (news of which has been hidden or dismissed by the press).
The organization is focusing on the fact that ivermectin has been previously approved for off-label use on humans.
“It has never been proper for the FDA to interfere with that essential part of the practice of medicine, and the FDA knows it,” AAPS informed the court. The FDA “insisted and continues to insist on interfering with the prescription of this safe medication by physicians in treating Covid-19,” AAPS added.AAPS General Counsel Andrew Schlafly pointed out to the court that the FDA “has engaged in a campaign of interference with the proper use by physicians of ivermectin, which has long been approved as fully safe for human use.” He alerted the court that once the FDA approves a medication as safe, then physicians have full authority to prescribe it to treat any illness, particularly a novel virus like Covid-19.
In another ivermectin-related court case, the Wisconsin Supreme Court will take up a lawsuit to force a hospital to administer ivermectin to a covid patient.
The Court agreed to look at the issue after a state appeals court rejected the demand of a Waukesha County man who wanted a judge to order a hospital to use ivermectin to treat his uncle who was hospitalized with COVID-19. Ivermectin is a drug used to treat parasites in horses as well as human beings.The case was one of five that the Supreme Court listed Friday as cases the justices will take up in the coming months.After Waukesha County resident John Zingzheim was put on a ventilator with COVID-19 in October 2021, his nephew, Allen Gahl, obtained an ivermectin prescription for his uncle from a doctor he had connected with online. Gahl holds a power of attorney for health care for his uncle.Doctors at the hospital, operated by Aurora Healthcare, refused to fill the prescription or administer the drug, saying it would be below the standard of care for COVID-19 patients.
Consider that a prominent UN official recently said: “We own the science, and we think that the world should know it, and the platforms themselves also do.” It becomes very easy to believe that bureaucratic distortions of social media platforms have stifled debate and honest dialog about early treatment options.
Here’s hoping the lawsuits help clear the way for the most honest and open evaluation of ivermectin and other inexpensive, readily available early treatment options for covid.
CLICK HERE FOR FULL VERSION OF THIS STORY